Additionally, loss of BMP6 was found to exacerbate liver fibrosis in a mouse model of non-alcoholic fatty liver disease, while recombinant BMP6 inhibited HSC activation and reduced profibrogenic and inflammatory gene expression in activated HSC in vitro [40]. This evidence concerns the gene BMP6 and Hepatic fibrosis.